Scott Ritter: Iran’s Retaliatory Attack ‘Reestablished Deterrence’ to Hold Israel, US in Check
By Svetlana Ekimenko | Sputnik | April 14, 2024
Iran’s mission to the United Nations stated earlier that Tehran’s retaliatory drone and missile attack against Israel had “concluded.” The “military action” was a response to Israel’s “aggression against our diplomatic premises in Damascus,” it said, adding that the strike “hit designated targets.”
By launching its retaliatory drone and missile attack on Israel, Iran “reestablished deterrence,” former UN weapons inspector Scott Ritter told Sputnik.
“Israel believed that it could launch a strike against Iran and suffer no consequence. That is no longer the case,” Ritter noted.
As Israeli military officials survey the damage done to their bases, “they understand the following: that Iran deliberately chose not to inflict extremely lethal action against Israel,” the analyst remarked.
Iran launched a massive drone and missile attack against Israel overnight, assisted by Hezbollah and the Yemeni Houthis. Over 300 projectiles were fired at Israeli territory from Iran, with Iran’s mission to the United Nations stating that its retaliatory attack on Israel had “concluded,” and that the strike “hit designated targets.” Israel’s military has claimed that 99% of the projectiles were intercepted.
Iran’s strike was designed to send a signal to Israel and the United States, “that it could do what it did in Nevatim, at Ramona, anywhere in Israel, anywhere in the Middle East, and there was nothing the United States or Israel could do in response.”
“This is deterrence. This means that in the future, if either Israel or the United States plan on carrying out an action against Iran, they have to weigh in the consequences of their actions knowing that Iran has the capacity to reach out and touch any place, any spot, any target in the region in Israel or out of Israel, and there’s nothing anybody could do to stop that,” the retired US Marine Corps intelligence officer said.
US President Joe Biden issued a statement on Iran’s attack against Israel after he spoke on the phone with Israeli Prime Minister Benjamin Netanyahu. The POTUS condemned the strike “in the strongest possible terms.” He also reaffirmed Washington’s “ironclad commitment” to help support Israel, and added that there were no attacks on US forces or facilities on Saturday, but that the US “will remain vigilant to all threats.”
Secretary of State Antony Blinken said the US does “not seek escalation,” but will “continue to support” Israel’s defense. “I will be consulting with allies and partners in the region and around the world in the hours and days ahead,” he added.
Weighing in on the flurry of talks between US and Israeli leaders, Scott Ritter said:
“This is why President Biden has been on the phone with Benjamin Netanyahu, the prime minister of Israel, telling him, ‘Do not retaliate.’ The United States will not be a partner in any offensive action against Iran. Not because the United States is friendly to Iran, but the United States understands the consequences that will accrue, should such an attack take place. The United States has been deterred against further action against Iran.”
The question uppermost at the moment is, “what will Israel do?” Ritter noted.
“Israel has been trying to lead the United States into a larger conflict with Iran for some time now. Indeed, some people have speculated that the Israeli attack against the Iranian Consulate in Damascus was designed for just that purpose… But the Iranians were very clever in designing their response – just like they did, when they retaliated against the United States for the assassination of Qasem Soleimani back in 2020,” Ritter said.
He recalled that at the time, Iran launched over a dozen missiles against the Al-Asad air base in Iraq, but Tehran gave Washington advance notice that that base was going to be struck. Thus, Iran ended up destroying empty buildings, Ritter recalled.
“But it demonstrated to the United States that it had the capacity to strike any American base in the region with extreme precision and kill as many Americans as they wanted – if they wanted to do that. And America was deterred against future action of that sort. Will Israel be deterred?” the analyst wondered.
No decision has been made yet regarding an Israeli response to the Iranian missile and drone attack, an Israeli official told The Times of Israel. It was added that a potential response would be discussed at a war cabinet meeting set for later on Sunday. Israel’s response to the Iranian attack will be coordinated with its allies, The New York Times reported earlier, citing an Israeli official.
After Iran’s unprecedented strike, Tel Aviv “understands that any escalation could mean the destruction of Israel,” Scott Ritter noted.
“Israel probably isn’t going to launch a response against Iran. Israel has been deterred from launching that response by the Iranian actions. In this case, we can say that operation ‘True Promise’ was an extraordinarily successful operation, not only for Iran, but indeed for the world, because Iranian deterrence now is a reality that can hold Israel and the United States in check,” Ritter said.
Iran describes response to Israeli attack as ‘legitimate defense’
Press TV – April 13, 2024
Iran’s permanent mission to the United Nations defends the country’s retaliation against the Israeli regime’s recent terrorist attack on the Islamic Republic’s diplomatic premises in the Syrian capital.
“Iran’s military action was based on Article 51 of the United Nations Charter concerning legitimate defense in response to the Zionist regime’s aggression against our diplomatic premises in Damascus,” the mission said in a statement on Saturday.
“The matter can be considered as concluded,” it added.
The mission, however, warned that if the Israeli regime perpetrated another mistake, Iran’s subsequent response could be “remarkably more intense.”
The statement concluded that the conflict was one between Iran and the rogue regime, “of which the United States should stay away.”
Iran’s Islamic Revolution Guards Corps (IRGC), on Saturday night, launched “extensive” retaliatory missile and drone strikes against the occupied territories, defining the mission as “Operation True Promise.”
The Israeli attack had resulted in the martyrdom of Brigadier General Mohammad Reza Zahedi, a commander of the IRGC’s Quds Force, his deputy, General Mohammad Hadi Haji Rahimi, and five of their accompanying officers.
The terrorist attack drew sharp condemnation from senior Iranian political and military leaders, who vowed “definitive revenge.”
On Thursday, the Iranian mission to the United Nations said the UN Security Council’s condemnation of the Israeli atrocity could have prevented the need for retaliation.
“Had the UN Security Council condemned the Zionist regime’s reprehensible act of aggression on our diplomatic premises in Damascus and subsequently brought to justice its perpetrators, the imperative for Iran to punish this rogue regime might have been obviated,” it said on the social media platform X Thursday.
End of Escalatory Ladder in Ukraine & MidEast – John Mearsheimer, Alexander Mercouris & Glenn Diesen
The Duran | April 12, 2024
$12 Billion Over 10 Years: Pharma, Medical Devices Industries Shell Out Direct Payments to US Physicians
By Brenda Baletti, Ph.D. | The Defender | April 11, 2024
The pharmaceutical and medical devices industries paid physicians more than $12 billion over 10 years, according to a study published last month in JAMA.
The analysis found the industries made 85,087,744 payments totaling $12.13 billion to 826,313 physicians — 57.1% of practicing physicians across 39 specialties.
Orthopedic surgeons, neurologists and psychiatrists, and cardiologists received the most money. Trauma surgeons and pediatric surgeons received the least.
The drugs with the highest payouts were blood thinners Xarelto and Eliquis, along with Humira, an immunosuppressant.
The three medical devices with the highest payouts were robotic surgery systems, da Vinci Surgical System and Mako SmartRobotics, and CoreValve Evolut, a heart valve.
“Money given to doctors has a purpose: it is for marketing,” cardiologist Dr. John Mandrola and co-author of the study wrote on his Substack. “If these direct payments to doctors did not work, industry would not spend billions.”
Dr. Andrew Foy, lead author of the paper, told The Defender in an email he thought some people might find the numbers “shocking” and he hoped it would renew interest in having conversations about physician-industry payments and facilitate more research.
The researchers tracked and compared payments made to physicians across and within specialties. They also identified the top 25 drugs and medical devices associated with the largest total payments.
The analysis included only money received for consulting, travel, food, entertainment, education, gifts, grants and honoraria. The researchers excluded other major external funding sources for physicians such as research funding and royalties.
They analyzed data from 2013-2022 in the Open Payments database, established in 2013 by the Physician Payments Sunshine Act as part of the Affordable Care Act.
Legislators designed the Sunshine Act to address growing public concerns about Big Pharma’s influence over doctors. At the time, several studies had shown that increased interaction with pharmaceutical representatives influenced physician prescribing behavior.
The act requires medical product manufacturers to disclose to the Centers for Medicare and Medicaid Services any payments or other transfers of value made to physicians or teaching hospitals. Open Payments publishes the payments on its website.
The analysis found that payments varied significantly across specialties. The highest-paid specialties like orthopedic surgery received $1.36 billion, and neurology and psychology specialties received $1.32 billion. The lowest-paid specialties received substantially less.
Pediatric surgeons and trauma surgeons received only $2.89 million and $6.96 million respectively.
Payments also varied significantly among physicians within the same specialty, with a small number of physicians in each specialty receiving the largest amounts of money — often exceeding $1 million — while the median physician received significantly less, typically less than $100, ranging from zero to $2,339.
“Our paper is a modest analysis. It does not explain the problem of financial conflicts of interest. But it is a lot of money. And it’s highly targeted to lucrative procedures,” Mandrola wrote.
“Industry influence is way too strong,” he added, and commonly results in medical devices being approved “despite dodgy evidence.”
He said many doctors believe collaboration between industry and physicians is a good thing that drives innovation. However, he said, these payments weren’t simply supporting collaboration.
“Most of it, I would argue, is for marketing and goodwill. Goodwill goes a long way to help establish practice patterns.”
Top drugs and devices on list net billions for pharma
The blood thinner Xarelto, used to prevent blood clots from forming due to an irregular heartbeat or after hip or knee replacement surgery, topped the payment list, accounting for $176.3 million.
The drug, made by Bayer and marketed by Janssen Pharmaceuticals, was Bayer’s top drug in 2023, generating about 4.1 billion euros in revenue.
Payments for Eliquis, another blood thinner used to treat the same conditions, amounted to $102.62 million. Pfizer and Bristol-Myers Squibb manufacture Eliquis.
Pfizer in 2023 brought in over $6.7 billion from the drug, its second-most profitable product behind the Comirnaty COVID-19 vaccine. Bristol-Myers Squibb’s sales topped $12 billion.
Eliquis costs U.S. customers 3 to 7 times more than customers in other high-income countries.
Humira, an immunosuppressant used to treat rheumatoid arthritis, psoriasis and other autoimmune conditions paid out $100.17 million to physicians. Over the last two decades, the drug netted over $200 billion for drugmaker AbbieVie, which listed the medication at $50,000 per year.
Bayer, Pfizer, Bristol-Myers Squibb and AbbieVie did not immediately respond to requests for comment.
Other top drugs included diabetes treatments Invokana, Jardiance, and Farxiga, Dupixent, a drug for allergic diseases, and Botox.
The two medical devices topping the list — da Vinci Surgical System, which paid $307.5 million, and Mako SmartRobotics, which paid $50 million — are machines for robotic-assisted surgeries.
Mako focuses on hip and knee replacements. Da Vinci netted approximately $7.12 billion in 2023 and investors were “blown away” by the “robot-fueled growth” of Mako SmartRobotics device installation for hip and knee replacements. Mako’s parent company Stryker made over $20 billion last year.
Several cardiology devices also made the list, including the third-highest payer CoreValve Evolut, another heart valve, Sapien 3 and LifeVest, a wearable defibrillator. They are all part of their parent companies’ multi-billion dollar product portfolios.
Conflicts of interest
The problem of physicians’ financial ties to pharmaceutical companies has plagued the industry for decades and garnered significant media attention.
Perhaps most famously, Purdue Pharma used misleading marketing to make massive profits from sales of opioids, sparking an epidemic. Nearly 645,000 Americans died from opioid overdose between 1999 and 2021.
However, Purdue Pharma’s policy of paying physicians has long been common practice. Research studies during the last two decades have found the vast majority of physicians accept payments and gifts from pharmaceutical companies. Influential studies include those by the Institute of Medicine and the Medicare Payments Advisory Commission that led to the passage of the Sunshine Act.
This latest study and other recent studies show that despite new mechanisms for transparency in payments, the payments continue.
And those payments are particularly high among physicians with prominent roles directing public policy.
For example, last year The New York Times revealed that while advisers at the National Academies of Sciences, Engineering, and Medicine were shaping public policy on opioids, they were also accepting payments from the Sackler family who owned Purdue Pharma.
Last month, The Defender reported that most of the nine new members appointed to the vaccine advisory committee for the Centers for Disease Control and Prevention have received substantial direct payments or research funding from Big Pharma — largely from the companies whose products they will be reviewing.
Foy said he thought a major part of the problem is that physicians and researchers believe that if they make their conflicts of interest transparent, the problem is resolved.
“As if someone cannot be transparent about their conflicts and highly biased at the same time,” he said.
He said that payments don’t necessarily lead directly to prescribing one specific drug for which a payment is received.
Instead, he said, he worries that the payments lead to, “overly enthusiastic recommendations or guidelines from medical organizations to use new products when they have not been sufficiently tested, or where the evidence is not strong enough, to recommend them over old standards or nothing at all (in some cases).”
Industry payments to physicians, Foy said, have a way of “tilting physicians’ sympathy toward industry and the ‘medical advancements’ that come from industry so that they (the physicians) more willingly adopt new products just for the sake of ‘industry advancement’ even if they don’t have a direct COI [conflict of interest] with that particular product.”
Physicians, he said, “become cheerleaders for industry and more open to adopting new products simply due to this attachment.”
For example, he said it is not uncommon at medical conferences for attendees to stand up and cheer results from “late-breaking” research studies whose “benefits are very rarely ever more than marginal, tiny, or ‘teensy-weensy’ at best.”
“I never understood it,” Foy wrote.
Direct payments aren’t the only way industry collaborates with physicians, Foy said.
Industry ads are featured on the homepage of medical journals and ads bombard physicians at major medical conferences.
He said this gives the impression that “the event is built around industry and its involvement.”
He said he doesn’t think that anyone tries to hide the relationships. “The main reason being, at least in my opinion, is that many physicians, perhaps even the majority, believe that physician-industry collaboration is a net benefit to patients and society,” he said.
“I don’t necessarily share that view; however, I don’t believe there is strong, objective evidence to support one side or the other.”
Brenda Baletti Ph.D. is a reporter for The Defender. She wrote and taught about capitalism and politics for 10 years in the writing program at Duke University. She holds a Ph.D. in human geography from the University of North Carolina at Chapel Hill and a master’s from the University of Texas at Austin.
This article was originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.
Game Over? Persian Gulf Powers Reportedly Refuse to Give US Access to Bases for Anti-Iran Strikes
By Ilya Tsukanov – Sputnik – 13.04.2024
Going back to the Gulf War in 1991, the US has depended on regional allies for large-scale military operations across the Middle East. Now, as tensions between Israel and Iran rise and the US-led unipolar world order comes under strain, America’s traditional partners are apparently refusing to walk in lock step with Washington.
Persian Gulf countries have reportedly told the United States not to launch any attacks against Iran from their territory or airspace amid seething regional tensions.
Sources, including a senior US official told the Middle East Eye that Gulf monarchies have been “working overtime” on the diplomatic track “to shut down avenues that could link them to a US reprisal against Tehran or its proxies from bases inside their kingdoms.”
The countries include regional heavyweights Saudi Arabia, the United Arab Emirates, Oman, and Kuwait, with their leaderships reportedly “raising questions” on the details of US basing agreements, and taking steps to prevent the use of their Iran-adjacent bases against the Islamic Republic.
NATO member Turkiye has also reportedly barred the US from using its airspace for strikes against Iran, but Sputnik has not been able to independently verify this information.
“It’s a mess,” a senior US official said, referring to the headache the Biden administration faces as it prepares for a potential Iranian retaliatory strike against its top regional ally Israel following Tel Aviv’s April 1 attack on the Iranian Embassy compound in Damascus, Syria.
The Middle East Eye report follows a report by Axios on Friday citing US officials who said that Iran has privately warned the US that it will target American forces in the Middle East if Washington gets involved in a military confrontation between Iran and Israel.
The US has an estimated 40,000+ military personnel at bases dotting the Middle East, including the Al Udeid Air Base in Qatar, which hosts at least 10,000 troops, and serves as the forward headquarters of United States Central Command – the combatant command responsible for military operations across the Middle East. Nearby Bahrain hosts up to 7,000 troops and the US Fifth Fleet – which operates in the Persian Gulf, the Red and Arabian Seas, and part of the Indian Ocean. The US also has a 15,000-troop garrison in Kuwait, at least 5,000 troops in the UAE, and about 2,700 troops and fighter jets at the Prince Sultan Air Base in Saudi Arabia. Oman hosts a few hundred US troops, and allows the US Air Force to conduct overflights and landings, and warships to make 80 port calls annually.
The Gulf powers’ increasingly independent foreign policy is potentially a major setback for Washington, which for many decades after World War II (and especially after the Cold War) was able to rely on the Persian Gulf monarchies for its military operations in the oil-rich region.
Regional countries led by Saudi Arabia and the UAE have taken a series of steps recently to wean themselves off of dependence on the US economically, politically and militarily, with Riyadh moving to break the petrodollar monopoly in the oil trade with China, pausing its military campaign against Yemen’s Houthi militia, restoring diplomatic ties with Iran and, together with Abu Dhabi, joining the BRICS Plus bloc.
The Palestinian-Israeli crisis has driven Gulf state leaders and their populations further from the idea of the establishing relations with Israel, and chilled ties with the US thanks to the Biden administration’s full-fledged support for Tel Aviv in the course of the Gaza War.
‘Russia turned off the gas’ – German leader

RT | April 12, 2024
Germans should blame Moscow and not Berlin for high energy prices, Chancellor Olaf Scholz said in an interview published on Friday. He claimed the embargo against Russia was necessary for defending Europe from “imperialism.”
Speaking with Die Tageszeitung, Scholz defended his government’s policy of unequivocal support for Ukraine.
“It’s about defending Europe’s peace order. Russia is waging an imperialist war and must not win,” he told the outlet. “Second: Russia stopped its gas deliveries, not us.”
Russia’s Gazprom delivered natural gas to Germany both via Ukraine – upholding the existing transit contracts – and via the Nord Stream pipeline, built under the Baltic Sea. Under pressure from the US, Germany blocked the certification of Nord Stream 2 in November 2021 – months before the Ukraine conflict escalated.
Berlin refused to certify Nord Stream 2 even after Nord Stream 1 was destroyed by explosive charges in September 2022. Western investigators have yet to name the culprit for the bombing.
According to Scholz, however, his government “developed new sources of supply for gas and oil and built terminals to import liquefied gas.” The LNG has come mainly from the US, at a much higher price.
“All of this has led to energy prices falling again,” the German chancellor said, arguing that his government prevented a ten-year economic crisis through “decisive action.”
Scholz seconded the message of his economy minister, Green leader Robert Habeck, who has argued that the German model of prosperity built around cheap Russian energy was over for good.
“The peacemaking effect of economic contacts was certainly overrated,” he told the Tageszeitung, claiming that Russia sacrificed its economic well-being by choosing violence. To defend its “democracy and freedom,” Germany needs a strong military, an efficient arms industry, and to support Ukraine, he insisted.
Scholz also brushed off the Germans’ concerns about the economy and inflation by saying that green energy and the pharmaceutical industry will soon turn things around.
On the same day his interview was published, Germany’s largest steelmaker Thyssenkrupp announced “a substantial reduction in production” at its Duisburg facility, laying off 13,000 employees. The company blamed “high energy costs and tight emission reduction regulations” as well as increased pressure from Asian imports.
All for One and One for All
By William Schryver – imetatronink – April 13, 2024
Russia, China, and Iran have now formed a de facto military and economic alliance — what they prefer to call a “partnership”.
In the case of Russia and China, a comprehensive full-spectrum partnership has emerged: military, economic, and monetary.
Trade between Russia and China has exploded both quantitatively and qualitatively.
Importantly, trade settlement is overwhelmingly denominated in rubles and renminbi. Use of the dollar and its international mechanisms is being aggressively deprecated.
Russia and China now conduct regular joint naval and air patrols of the western Pacific, from Alaska to the South China Sea.
Russia, China, and Iran conduct regular joint exercises in the Arabian Sea. Those exercises have increased in both scope and frequency in recent years.
Both Russia and China are investing vast sums of capital in Iran, much of it in the energy sector and in ambitious transportation projects aiming to construct fast and efficient trade corridors linking China, Iran, and Russia as primary nodes of Eurasian commerce.
Arms and technology transfers between the three countries have reached unprecedented levels.
Russian foreign minister Sergey Lavrov just concluded several days of talks with Chinese leaders, including both Wang Yi and Xi Jinping. In its report of the talks, the Chinese government’s flagship media organ, Global Times, summarized (in the words of prominent CPC commentator Li Haidong) the current state of the Russia/China relationship:
“China and Russia will not target any third party, but if hegemonic forces threaten China and Russia, or threaten world peace, China and Russia will stand together and fight to protect their own interests and safeguard world peace together.”
It is increasingly evident that Russia, China, and Iran recognize that an attack against any one of them would constitute an existential threat to them all. The strategic interests of all three countries are now inextricably intertwined.
Most importantly, they are united in a single overriding strategic objective: to dismantle the dominion of the long-reigning Anglo-American empire.
Naturally, the rapidly waning global hegemon is not inclined to relinquish its throne without a fight. What form that fight takes remains to be seen. But if the empire attempts to preserve its so-called “rules-based international order” via force of arms, it is essential to understand this incontrovertible reality:
In order for the United States to make war against any ONE of Russia, China, or Iran, it would be necessary to effectively vacate every major US base on the planet in order to concentrate enough military power to undertake the mission.
In a putative war between the United States and Iran, both Russia and China would actively support Iran. I’m not suggesting Russian or Chinese forces would fight alongside Iranians — although that could happen. But it would likely not be necessary. Iran would simply be supplemented with arms and other logistical necessities from both its partners — and quite possibly taken under their nuclear umbrella in an explicit act of deterrence.
Additionally, in consequence of the US weakening its force posture in Europe and the western Pacific in a bid to militarily subdue Iran, Russia and China would be enabled to apply immense pressure to western logistics, trade, and political influence in those regions. This is not to suggest that China would invade Taiwan or Russia would invade the Baltics or Poland. They would need only to exert their dominant influence in what were previously considered to be unassailable American imperial domains in east Asia and Europe.
The empire is stretched so thin and its potential for power projection is so diluted that undertaking even one Big War would be enough to bring the entire house of cards tumbling down.
This is the harsh reality the Masters of Empire are now facing, and no amount of mythologizing about the “limitless” power at their disposal can change it.
There is a vast difference between imagined power and the actual ability to project and sustain power against the adversaries the United States military must now face and defeat in order to prevent or even meaningfully delay the end of American global hegemony.
And, to the extent Russia, China, and Iran are determined to act all for one and one for all, they represent a combination of global military and economic power that cannot be defeated.
US has ‘no viable plan’ for Ukraine – senator
RT | April 12, 2024
Kiev cannot win against Moscow because it has run out of men and needs more weapons and ammunition than Washington could possibly provide, US Senator J.D. Vance said on Friday.
Earlier this week, Senate Majority Leader Chuck Schumer argued that “the biggest reason Ukraine is losing the war is because the hard-right in the Congress has paralyzed the US from acting.” The New York Democrat claimed that a small group of Republicans have been holding up a vital $60 billion aid package for Kiev.
In an op-ed published by the New York Times, Vance addressed Schumer’s claim and accused President Joe Biden of having “failed to articulate even basic facts” about what Ukraine needs and the reality on the ground.
“The Biden administration has no viable plan for the Ukrainians to win this war,” Vance argued.
“Ukraine’s challenge is not the GOP; it’s math,” the Ohio Republican wrote. “Ukraine needs more soldiers than it can field, even with draconian conscription policies. And it needs more matériel than the United States can provide.”
Not only is $60 billion a fraction of what Ukraine would need to turn the tide, Americans “lack the capacity to manufacture the amount of weapons Ukraine needs us to supply to win the war,” Vance argued.
He pointed to the fact that the US can make 360,000 shells for 155mm artillery per year, “less than a tenth of what Ukraine says it needs,” and that’s after doubling prewar production capacity.
Vance also took aim at the White House’s messaging that funding Kiev is good for US military industry.
“The notion that we should prolong a bloody and gruesome war because it’s been good for American business is grotesque. We can and should rebuild our industrial base without shipping its products to a foreign conflict,” he wrote.
The US insistence on not negotiating with Russia is “absurd” and Ukrainian President Vladimir Zelensky’s goal of restoring Ukraine’s 1991 borders is “fantastical,” Vance added. He urged Kiev to dig in and hold until some kind of peace can be brokered by Washington.
Earlier this week, however, Zelensky said Ukraine was planning yet another counteroffensive – after the costly failure of last summer’s operation – but needed even more weapons and ammunition from the West.
Abu Ghraib survivors to get their day in court
RT | April 12, 2024
Twenty years on from reports that the US military was torturing prisoners at Iraq’s Abu Ghraib prison, three survivors will finally get a chance to bring their claims before an American jury.
A trial in the civil lawsuit filed by former Abu Ghraib inmates against the US military contractor that they blame for their suffering is scheduled to begin on Monday in a federal court near Washington. The private security contractor, CACI International, has strung the case along for 16 years by making over 20 unsuccessful attempts to have the lawsuit dismissed.
CACI, which supplied the interrogators who worked at Abu Ghraib, has insisted that its employees weren’t accused of abusing detainees. The Virginia-based company also has argued that as a Pentagon contractor, it should be protected by the government’s sovereign immunity against the torture allegations.
However, the plaintiffs claimed that CACI set the conditions for their torture by directing or encouraging abuses by military guards, at least partly to “soften up” prisoners for interrogations. All three of the former detainees are Iraqi civilians who were held at Abu Ghraib until eventually being released without charges.
The trial will be “an exceedingly rare opportunity for accountability for the egregious harms suffered by Iraqis after the US invasion in 2003,” according to a statement earlier this month by the Center for Constitutional Rights, a US group that is representing the plaintiffs. “In fact, this is the first lawsuit where victims of US post-9/11 torture will get their day in court.”
The Abu Ghraib scandal first came to public attention in April 2004, when photos of abused prisoners and their smiling US guards were published. At the time, CBS News aired a report describing the abuse and showing American soldiers taunting naked prisoners. The abuses included stacking nude prisoners in pyramids or dragging them by leashes around their necks. Others were threatened by dogs or hooded and attached to electrical wires.
One of the plaintiffs, former Al-Jazeera reporter Salah Al-Ejaili, claimed he was forced to wear women’s underwear, terrorized by dogs, deprived of sleep, and put in stress positions that caused him to vomit black liquid. Another survivor, Suhail Al-Shimari, has claimed that he suffered beatings, electrical shocks, and sexual assaults.
CACI has argued that its employees weren’t in a position to give orders to military police and that the US government was responsible for setting the conditions at Abu Ghraib. The company has continued to receive lucrative US government contracts for the past two decades, and only low-level soldiers were criminally prosecuted for the abuses.
A Pentagon investigation found that acts of “brutality and purposeless sadism” occurred at the prison at the hands of military police and US intelligence agency personnel. Retired US Army General Antonio Taguba, who led the investigation, concluded that at least one CACI interrogator should be held accountable for directing military police to set the conditions that led to abuses. Taguba will reportedly testify at the Abu Ghraib trial.
